Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline

BACKGROUND: While substantial progress has been made in the development of disease-modifying medications for multiple sclerosis (MS), a high percentage of treated patients still show progression and persistent inflammatory activity. Autologous haematopoietic stem cell transplantation (AHSCT) aims at...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayas, Antonios, Berthele, Achim, Blank, Norbert, Dreger, Peter, Faissner, Simon, Friese, Manuel A., Gerdes, Lisa-Ann, Grauer, Oliver Martin, Häussler, Vivien, Heesen, Christoph, Janson, Dietlinde, Korporal-Kuhnke, Mirjam, Kowarik, Markus, Kröger, Nikolaus, Lünemann, Jan D., Martin, Roland, Meier, Uwe, Meuth, Sven, Muraro, Paolo, Platten, Michael, Schirmer, Lucas, Stürner, Klarissa Hanja, Stellmann, Jan Patrick, Scheid, Christof, Bergh, Florian Then, Warnke, Clemens, Wildemann, Brigitte, Ziemssen, Tjalf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540601/
https://www.ncbi.nlm.nih.gov/pubmed/37780055
http://dx.doi.org/10.1177/17562864231180730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540601/
https://www.ncbi.nlm.nih.gov/pubmed/37780055
http://dx.doi.org/10.1177/17562864231180730

Ejemplares similares